SAWAI GROUP HOLDINGS Co.,Ltd. (4887.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

12.4x

EV/EBITDA

12.8x

Market Cap

JPY 181.60B

MomentumView details →

1D Return

+0.16%

YTD Return

−33.09%

RSI (14)

39.3

ValuationView details →

P/E (Fwd)

12.4x

EV/EBITDA

12.8x

Market Cap

JPY 181.60B

RSI (14)

39.3

MomentumView details →

1D Return

+0.16%

YTD Return

−33.09%

ProfitabilityView details →

Gross Margin

28.08%

Net Margin

−1.36%

EBITDA Margin

9.61%

ROE (TTM)

−1.53%

ROA (TTM)

−0.73%

Asset Turnover

0.55x

GrowthView details →

Revenue YoY

+9.06%

EPS YoY

—

FCF YoY

+537.62%

Revenue CAGR 3Y

−0.83%

EPS CAGR 3Y

−42.23%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.69x

Current Ratio

2.25x

Quick Ratio

1.08x

Div Yield

3.50%

Div Rate

—

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

200.68B

Net Income (TTM)

−2.74B

Op. CF (TTM)

20.29B

Next earningsNov 6, 2026 →

Latest newsMore news →

Sawai Pharmaceutical, under Sawai Group Holdings, will discontinue 46 generic drug products as inventory runs out, including 39 due to a major product portfolio restructuring to improve production efficiency and ensure stable supply of generics.29d ago

Similar companies

TOWA PHARMACEUTICAL CO.,LTD.4553.T KISSEI PHARMACEUTICAL CO.,LTD.4547.T KAKEN PHARMACEUTICAL CO.,LTD.4521.T GNI Group Ltd.2160.T PeptiDream Inc.4587.T Nippon Shinyaku Co.,Ltd.4516.T Find similar companies →

Latest newsMore news →

Sawai Pharmaceutical, under Sawai Group Holdings, will discontinue 46 generic drug products as inventory runs out, including 39 due to a major product portfolio restructuring to improve production efficiency and ensure stable supply of generics.29d ago